Incannex Healthcare INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Incannex Healthcare Inc. has adjourned its 2025 Annual Meeting of Stockholders to January 15, 2026, due to a lack of quorum caused by an administrative error.
NASDAQ
Incannex Healthcare Inc. expects to adjourn its 2025 Annual Meeting due to an administrative error classifying the Auditor Ratification Proposal as non-routine, hindering broker discretionary voting.
NASDAQ
Incannex Healthcare Inc. announces its Annual Meeting of Stockholders for December 18, 2025, to vote on director elections and auditor ratification.
NASDAQ
Incannex Healthcare Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 18, 2025, to elect directors and ratify its independent auditor.
NASDAQ
Incannex Healthcare modifies agreements with warrant holders to allow for sales of common stock through an at-the-market (ATM) facility, with proceeds used to reduce warrant share amounts.
NASDAQ
Incannex Healthcare is holding a special meeting to seek stockholder approval for several key proposals, including increasing authorized shares, a reverse stock split, and amendments to its equity incentive plan.
NASDAQ
DEF 14A: Incannex Healthcare Seeks Stockholder Approval for Key Proposals at Upcoming Annual Meeting
Incannex Healthcare is holding its 2024 annual meeting on December 11, 2024, seeking stockholder approval for director election, auditor ratification, and key equity issuance proposals related to financing agreements.